Veracyte Common Stock Net 2012-2025 | VCYT
Veracyte common stock net from 2012 to 2025. Common stock net can be defined as the value of common equity ownership.
| Veracyte Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| Veracyte Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2011-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.117B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.768B | 85.31 |
| Thermo Fisher Scientific (TMO) | United States | $153.059B | 18.51 |
| Edwards Lifesciences (EW) | United States | $45.878B | 30.08 |
| Alcon (ALC) | Switzerland | $43.544B | 29.43 |
| IDEXX Laboratories (IDXX) | United States | $43.134B | 49.57 |
| DexCom (DXCM) | United States | $34.227B | 52.90 |
| IQVIA Holdings (IQV) | United States | $27.263B | 15.27 |
| Mettler-Toledo (MTD) | United States | $24.414B | 29.03 |
| STERIS (STE) | Ireland | $23.631B | 26.03 |
| Waters (WAT) | United States | $20.771B | 29.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.802B | 0.00 |
| Hologic (HOLX) | United States | $14.521B | 15.78 |
| Sysmex ADR (SSMXY) | Japan | $10.950B | 31.06 |
| Penumbra (PEN) | United States | $9.938B | 78.00 |
| Masimo (MASI) | United States | $9.121B | 33.64 |
| Globus Medical (GMED) | United States | $7.990B | 19.04 |
| Glaukos (GKOS) | United States | $5.902B | 0.00 |
| Teleflex (TFX) | United States | $5.230B | 8.63 |
| TransMedics (TMDX) | United States | $4.533B | 98.54 |
| Integer Holdings (ITGR) | United States | $4.291B | 22.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.187B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.455B | 14.62 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.947B | 17.50 |
| Alphatec Holdings (ATEC) | United States | $1.623B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.242B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.954B | 5.07 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| Beta Bionics (BBNX) | United States | $0.631B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.566B | 8.81 |
| RxSight (RXST) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.514B | 12.05 |
| AxoGen (AXGN) | United States | $0.494B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.474B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.432B | 11.50 |
| AngioDynamics (ANGO) | United States | $0.403B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.372B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| 908 Devices (MASS) | United States | $0.256B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.33 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |